Point72 (Difc) LTD Exelixis, Inc. Transaction History
Point72 (Difc) LTD
- $3.17 Trillion
- Q1 2024
A detailed history of Point72 (Difc) LTD transactions in Exelixis, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 25,559 shares of EXEL stock, worth $561,275. This represents 0.02% of its overall portfolio holdings.
Number of Shares
25,559Holding current value
$561,275% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
460Shares Held
246MCall Options Held
1.7MPut Options Held
1.02M-
Black Rock Inc. New York, NY34.9MShares$766 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.8MShares$677 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA26.7MShares$586 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.1MShares$332 Million0.56% of portfolio
-
State Street Corp Boston, MA13.1MShares$287 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $7.07B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...